Alejandra Carvajal
CIK 1645755 · Chief Legal Officer · last filed 2026-08-05
Alejandra Carvajal is a Chief Legal Officer who has filed 39 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for CTMX, was dated Aug 5, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $339.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$339.0K
4
39
-$1.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTMX | Chief Legal Officer | 100,000 | $3.39 | $339.0K | $0 | 1 | 2026-08-05 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | SVP, Chief Legal Officer | 0 | $29.08 | $0 | -$79.2K | 12 | 2026-01-06 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Chief Legal Officer | 0 | — | — | -$1.39M | 20 | 2020-10-01 |
| Dare Bioscience, Inc. (CERU) Delisted | VP, General Counsel | — | — | — | $0 | 4 | 2017-01-09 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-05 | CTMX | Grant (A) | +100,000 | $0 | EDGAR |
| 2026-01-06 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | −3,131 | $0 | EDGAR |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +7,404 | -$3.0K | EDGAR |
| 2025-01-17 | Mersana Therapeutics, Inc. (MRSN) Delisted | Notice (144) | −5,096 | -$3.1K | EDGAR |
| 2025-01-16 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +1,548 | -$600 | EDGAR |
| 2025-01-15 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +5,628 | -$2.2K | EDGAR |
| 2024-10-07 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +36,313 | -$27.2K | EDGAR |
| 2024-10-07 | Mersana Therapeutics, Inc. (MRSN) Delisted | Notice (144) | −8,089 | -$16.3K | EDGAR |
| 2024-01-17 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | +7,077 | -$11.9K | EDGAR |
| 2023-09-07 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.